platinum has been researched along with Abdominal Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, DT; Dieterich, S; Hofmann, LV; Kothary, N; Louie, JD; Sze, DY | 1 |
Hoskins, WJ; Jones, WB; Lewis, JL; Rubin, SC; Vaccarello, L; Vlamis, V; Wong, G | 1 |
Chen, JT; Fujimoto, I; Hamada, T; Hasumi, K; Hirai, Y; Nakayama, K; Shimizu, Y; Teshima, H; Yamauchi, K; Yokosuka, K | 1 |
3 other study(ies) available for platinum and Abdominal Neoplasms
Article | Year |
---|---|
Percutaneous implantation of fiducial markers for imaging-guided radiation therapy.
Topics: Abdominal Neoplasms; Adult; Aged; Contrast Media; Equipment Design; Female; Gold; Humans; Male; Middle Aged; Platinum; Prostheses and Implants; Radiosurgery; Radiotherapy Planning, Computer-Assisted; Thoracic Neoplasms; Tomography, X-Ray Computed | 2009 |
Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Topics: Abdominal Neoplasms; Adult; Aged; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Pelvic Neoplasms; Platinum; Reoperation; Retrospective Studies; Survival Analysis | 1995 |
[CDDP-ACR treatment in patients with recurrent ovarian cancer with prior chemotherapy containing CDDP--a preliminary study of a 14-day continuous infusion of CDDP with ACR].
Topics: Abdominal Neoplasms; Aclarubicin; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Platinum; Recurrence; Remission Induction; Thrombocytopenia | 1989 |